BlueScope Steel Shares Slip After Board Rejects A$13.2 Billion Takeover Bid 
FCC Exempts Select Foreign-Made Drones From U.S. Import Ban Until 2026 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026 
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move 
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling 
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges 
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids 
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook 
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal 
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut 
xAI Cash Burn Highlights the High Cost of Competing in Generative AI 
Chevron Seeks Expanded U.S. License to Boost Venezuelan Oil Exports Amid Sanctions Talks 
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content 
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom 
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability 
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny 
NEW YORK, April 06, 2016 -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a shareholder class action lawsuit has been filed in the United States District Court for the Southern District of New York against Amaya Inc. ("Amaya" or the "Company") (NASDAQ:AYA) on behalf of all investors in Amaya securities purchased between June 8, 2015 and March 23, 2016, inclusive (“Class Period”).
Shareholders who have incurred losses in securities are urged to contact the firm immediately at [email protected] or (800) 575-0735 or (212) 545-4774. In addition, investors who purchased shares of Amaya Inc. (TSX:AYA) shares on the Toronto Stock Exchange (“TSX”) are encouraged to contact the firm to obtain additional information.
If you purchased shares of Amaya Inc., you may, no later than May 24, 2016, request that the Court appoint you lead plaintiff of the proposed class.
On March 23, 2016, the Quebec securities regulator, Autorite des March Financiers (the "AMF"), announced that it had charged Amaya's CEO and founder, David Baazov, and other key insiders with insider trading. The AMF has been working in conjunction with the Royal Canadian Mounted Police, Quebec Police and U.S. regulators to determine why a large number of investors bought shares of Amaya's stock prior to its $3.8 billion merger with industry stalwart PokerStars, and if these share purchases were based upon insider information.
The AMF has stated that its investigation is ongoing and it may file additional charges. On news of the charges against Baazov, Amaya stock declined approximately 20%, resulting in a loss of market capitalization to shareholders of approximately $275 million. Baazov has since taken indefinite leave from Amaya to address the charges.
Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.
If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein Adler Freeman & Herz LLP by telephone at (800) 575-0735, via e-mail at [email protected], or visit our website at www.whafh.com. All e-mail correspondence should make reference to the “Amaya class action.”
Contact: Wolf Haldenstein Adler Freeman & Herz LLP Gregory Nespole, Esq. Gregory Stone, Director of Case and Financial Analysis Email: [email protected], [email protected] or [email protected] Tel: (800) 575-0735 or (212) 545-4774
